Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Scilla Maritima 3 X Drops ; Globules ; Granules is a Health Canada–registered human drug (DIN 02234115) held by Homeocan Inc., containing Squill. Health Canada lists its status as Cancelled Post Market (status date 04 Aug 2009). Nexara Health has matched 3 registrations of Squill across 1 other regulated market, 2 of them in the same strength and dosage form.

Health Canada registration

DIN02234115
Brand nameScilla Maritima
Active ingredientSquill
Strength3 X
Dosage formDrops ; Globules ; Granules
RouteOral
CompanyHomeocan Inc.
StatusCancelled Post Market — 04 Aug 2009
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Squill registered in other markets

3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
Hong KongExtract For Making Squill Liq ExtractTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office
Hong KongSquill Liquid Extract BPTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office
Hong KongSquill OxymelTranso-Pharm (Hong Kong) LimitedRegisteredDH Drug Office

See every manufacturer of Squill worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Scilla Maritima (DIN 02234115) marketed in Canada?

No. Health Canada lists DIN 02234115 as Cancelled Post Market as of 04 Aug 2009.

Who holds the Canadian licence for this product?

Homeocan Inc. is the company of record in the Health Canada Drug Product Database.

Is Squill registered outside Canada?

Yes — Nexara Health has matched 3 registrations in 1 other market, including 2 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02234115, status date 2009-08-04; national medicine registries: DH Drug Office. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02234115, status date 2009-08-04; national medicine registries: DH Drug Office.

Health Canada Drug Product Database (DPD), DIN 02234115, status date 2009-08-04; national medicine registries: DH Drug Office. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.